Abstract OT1-1-11: TBCRC 022: Phase II Trial of Neratinib for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast cancer and Brain Metastases
Year: 2012
Type: conference-abstract
Source: Cancer Research
Authors: RA Freedman, RS Gelman, JS Wefel, IE Krop, ME Melisko, A Ly, NYR Agar, RM Connolly, KL Blackwell, LM Nabell, JN Ingle, CH Van Poznak, SL Puhalla, PA Niravath, N Ryabin, AC Wolff, EP Winer, N Lin
Institutions: Brigham and Women's Hospital, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Johns Hopkins University, Duke University, University of Alabama, University of California, San Francisco, University of Michigan, University of Alabama at Birmingham, Dana-Farber Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1983864539